NO894296D0 - Fremgangsmaate for behandling av leddgikt og betennelsessykdommer. - Google Patents
Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.Info
- Publication number
- NO894296D0 NO894296D0 NO894296A NO894296A NO894296D0 NO 894296 D0 NO894296 D0 NO 894296D0 NO 894296 A NO894296 A NO 894296A NO 894296 A NO894296 A NO 894296A NO 894296 D0 NO894296 D0 NO 894296D0
- Authority
- NO
- Norway
- Prior art keywords
- arthy
- procedure
- treatment
- inflammatory diseases
- inflammatory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/293,196 US4863928A (en) | 1989-01-04 | 1989-01-04 | Method of treatment for arthritic and inflammatory diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
NO894296D0 true NO894296D0 (no) | 1989-10-27 |
NO894296L NO894296L (no) | 1990-07-05 |
Family
ID=23128099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO89894296A NO894296L (no) | 1989-01-04 | 1989-10-27 | Fremgangsmaate for behandling av leddgikt og betennelsessykdommer. |
Country Status (9)
Country | Link |
---|---|
US (1) | US4863928A (no) |
EP (1) | EP0377272A3 (no) |
JP (1) | JPH02184628A (no) |
AU (1) | AU619937B2 (no) |
CA (1) | CA1333772C (no) |
DK (1) | DK674389A (no) |
IL (1) | IL91302A (no) |
NO (1) | NO894296L (no) |
ZA (1) | ZA898013B (no) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5013739A (en) * | 1986-10-07 | 1991-05-07 | Bernard Bihari | Method of treating chronic fatigue syndrome using an opiate receptor antagonist |
US4857533A (en) * | 1988-12-15 | 1989-08-15 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for autoimmune diseases |
US5086058A (en) * | 1990-06-04 | 1992-02-04 | Alko Ltd. | Method for treating alcoholism with nalmefene |
US6096756A (en) * | 1992-09-21 | 2000-08-01 | Albert Einstein College Of Medicine Of Yeshiva University | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists |
US5376662A (en) * | 1993-12-08 | 1994-12-27 | Ockert; David M. | Method of attenuating nerve injury induced pain |
SE9304236D0 (sv) * | 1993-12-22 | 1993-12-22 | Astra Ab | New use |
US5878750A (en) * | 1996-11-14 | 1999-03-09 | Clemens; Anton H. | Method of treating the syndrome of coronary heart disease risk factors in humans |
US6203813B1 (en) | 1997-01-13 | 2001-03-20 | Lance L. Gooberman | Pharmaceutical delivery device and method of preparation therefor |
AU1807401A (en) * | 1999-11-30 | 2001-06-12 | Corixa Corporation | Compositions and methods for therapy and diagnosis of breast cancer |
US20040024004A1 (en) * | 2001-05-04 | 2004-02-05 | Sherman Barry M. | Novel compositions and methods for enhancing potency or reducing adverse side effects of opioid agonists |
US6528520B2 (en) * | 2000-08-15 | 2003-03-04 | Cpd, Llc | Method of treating the syndrome of coronary heart disease risk factors in humans |
US6846831B2 (en) | 2000-08-15 | 2005-01-25 | Cpd, Llc | Method of treating the syndrome of lipodystrophy |
US6262062B1 (en) | 2000-08-15 | 2001-07-17 | Cpd, Llc | Method of treating the syndrome of coronary heart disease risk factors in humans |
US7879211B2 (en) * | 2001-07-13 | 2011-02-01 | Arkray, Inc. | Analyzing instrument, lancet-integrated attachment for concentration measuring device provided with analyzing instrument, and body fluid sampling tool |
WO2003097608A2 (en) * | 2002-05-17 | 2003-11-27 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
US7501433B2 (en) * | 2002-05-17 | 2009-03-10 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
US7923454B2 (en) | 2002-05-17 | 2011-04-12 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
US6972291B2 (en) * | 2002-07-02 | 2005-12-06 | Bernstein Richard K | Method for reducing food intake |
PL2368553T3 (pl) | 2003-04-08 | 2015-05-29 | Progenics Pharm Inc | Preparaty farmaceutyczne zawierające metylonaltrekson |
US20050038062A1 (en) * | 2003-04-14 | 2005-02-17 | Burns Lindsay H. | Methods and materials for the treatment of pain comprising opioid antagonists |
US8017622B2 (en) * | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
US20060009478A1 (en) * | 2003-10-15 | 2006-01-12 | Nadav Friedmann | Methods for the treatment of back pain |
US20050245557A1 (en) * | 2003-10-15 | 2005-11-03 | Pain Therapeutics, Inc. | Methods and materials useful for the treatment of arthritic conditions, inflammation associated with a chronic condition or chronic pain |
AU2005244852B2 (en) | 2004-05-12 | 2011-09-22 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods related to the treatment of neurodegenerative and inflammatory conditions |
US9662325B2 (en) | 2005-03-07 | 2017-05-30 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
US8524731B2 (en) | 2005-03-07 | 2013-09-03 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
US8518962B2 (en) | 2005-03-07 | 2013-08-27 | The University Of Chicago | Use of opioid antagonists |
MX2007010833A (es) | 2005-03-07 | 2009-02-17 | Univ Chicago | Uso de antagonistas opioides para atenuar proliferacion y migracion de células endoteliales. |
AR057035A1 (es) | 2005-05-25 | 2007-11-14 | Progenics Pharm Inc | SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS |
AR057325A1 (es) | 2005-05-25 | 2007-11-28 | Progenics Pharm Inc | Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos |
US20080194611A1 (en) * | 2005-06-03 | 2008-08-14 | Alverdy John C | Modulation of Cell Barrier Dysfunction |
CA2609985A1 (en) * | 2005-06-03 | 2007-05-10 | The University Of Chicago | Modulation of cell barrier dysfunction |
EP2012790A4 (en) * | 2006-04-19 | 2009-07-01 | Smith Jill P | TREATMENT OF INFLAMMATORY AND ULCEROUS DISEASES OF THE COLON USING OPIOID ANTAGONISTS |
US20070259939A1 (en) * | 2006-05-04 | 2007-11-08 | Accelerated Technologies | Using naltrexone as a multi-purpose health supplement to improve the human condition and preventing multiple diseases and infirmities by stimulating immune system vitality and robustness |
ES2540551T3 (es) | 2007-03-29 | 2015-07-10 | Wyeth Llc | Antagonistas de receptores opioides periféricos y usos de los mismos |
JP2010522756A (ja) | 2007-03-29 | 2010-07-08 | プロジェニックス ファーマシューティカルズ,インコーポレーテッド | 結晶形およびその使用 |
AU2008233129B2 (en) | 2007-03-29 | 2014-03-20 | Progenics Pharmaceuticals, Inc. | Peripheral opioid receptor antagonists and uses thereof |
CN101959892B (zh) | 2008-02-06 | 2014-01-08 | 普罗热尼奇制药公司 | (r),(r)-2,2’-二-甲基纳曲酮的制备和用途 |
JP5647098B2 (ja) | 2008-03-21 | 2014-12-24 | ザ ユニヴァーシティー オヴ シカゴ | オピオイド拮抗薬とmTOR阻害薬を用いた治療 |
CA2676881C (en) | 2008-09-30 | 2017-04-25 | Wyeth | Peripheral opioid receptor antagonists and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU538186B2 (en) * | 1980-03-07 | 1984-08-02 | Scotia Holdings Plc | Prostaglandin precursors |
HU196376B (en) * | 1985-05-23 | 1988-11-28 | Sandoz Ag | Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds |
US4760069A (en) * | 1985-09-23 | 1988-07-26 | Nova Pharmaceutical Corporation | Oximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonists |
US4673679A (en) * | 1986-05-14 | 1987-06-16 | E. I. Du Pont De Nemours And Company | Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration |
FR2609632B1 (fr) * | 1987-01-21 | 1991-03-29 | Shelly Marc | Nouvelle application therapeutique de la 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinon-6-one et les compositions pharmaceutiques destinees a cet usage |
US4857533A (en) * | 1988-12-15 | 1989-08-15 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for autoimmune diseases |
-
1989
- 1989-01-04 US US07/293,196 patent/US4863928A/en not_active Expired - Fee Related
- 1989-08-14 IL IL9130289A patent/IL91302A/en not_active IP Right Cessation
- 1989-08-21 JP JP1215893A patent/JPH02184628A/ja active Pending
- 1989-08-22 CA CA000608936A patent/CA1333772C/en not_active Expired - Fee Related
- 1989-09-18 EP EP19890309448 patent/EP0377272A3/en not_active Ceased
- 1989-10-23 ZA ZA898013A patent/ZA898013B/xx unknown
- 1989-10-27 NO NO89894296A patent/NO894296L/no unknown
- 1989-12-29 DK DK674389A patent/DK674389A/da not_active Application Discontinuation
-
1990
- 1990-01-03 AU AU47630/90A patent/AU619937B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
DK674389D0 (da) | 1989-12-29 |
EP0377272A2 (en) | 1990-07-11 |
IL91302A0 (en) | 1990-03-19 |
EP0377272A3 (en) | 1991-09-25 |
DK674389A (da) | 1990-07-05 |
ZA898013B (en) | 1990-08-29 |
AU619937B2 (en) | 1992-02-06 |
IL91302A (en) | 1994-05-30 |
AU4763090A (en) | 1990-08-30 |
JPH02184628A (ja) | 1990-07-19 |
NO894296L (no) | 1990-07-05 |
CA1333772C (en) | 1995-01-03 |
US4863928A (en) | 1989-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO894296L (no) | Fremgangsmaate for behandling av leddgikt og betennelsessykdommer. | |
NO911952L (no) | Behandling av tilstander og sykdommer samt midler derfor. | |
NO883540D0 (no) | Fremgangsmaate og anlegg for behandling av slam. | |
NO893240L (no) | Anvendelse av alfa-aminoborsyrederivater til profylaktisk og behandling av virussykdommer. | |
NO890045L (no) | Baatskrog og fremgangsmaate for fremstilling og belegging derav. | |
NO953254D0 (no) | Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter | |
NO882940D0 (no) | Fremgangsmaate for fremstilling av castanosperminestere og glycosider. | |
NO922531D0 (no) | Middel for forhindring av og behandling av fiskesykdommer | |
NO913117D0 (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
NO883220D0 (no) | Innretning og preparat for behandling av gommene. | |
NO880292D0 (no) | Fremgangsmaate for behandling av humle. | |
NO881713L (no) | Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere. | |
NO920983D0 (no) | Fremgangsmaate for behandling av nevrodegenerative tilstander | |
NO891630D0 (no) | Fremgangsmaate og anordning for fremstilling av diafragmer. | |
NO892257L (no) | Fremgangsmaate og anordning for oppfoering av gulvkonstruksjoner. | |
NO882336L (no) | Fremgangsmaate for fremstilling av 5-metoksyalkylammoniun-tetrahydrofuraner og tetrahydrotiofener. | |
NO905543D0 (no) | Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer. | |
NO884635D0 (no) | Fremgangsmaate for behandling av most. | |
NO823424L (no) | Fremgangsmaate til fremstilling og behandling av ferrokrom | |
NO874487D0 (no) | Framgangsmaate for tilvirkning av poelser og liknende produkter. | |
DK670588D0 (da) | Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet | |
NO912279D0 (no) | Fremgangsmaate for fremstilling og anvendelse av eksplosjonssikre 1-dimetylamino-3-dimetylimino-2-arylprop-1-en-salter. | |
FI890595A (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara tiadiazoler. | |
NO902968L (no) | Fremgangsmaate for behandling av boreslam. | |
NO905643D0 (no) | Fremgangsmaate for behandling av manganslam. |